Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5578
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) ; day:3 ; month:10 ; year:2018 ; pages:1-12
Molecular psychiatry ; (3.10.2018), 1-12
- Urheber
-
Fava, Maurizio
- Beteiligte Personen und Organisationen
-
Freeman, Marlene P.
Flynn, Martina
Judge, Heidi
Hoeppner, Bettina B.
Cusin, Cristina
Ionescu, Dawn F.
Mathew, Sanjay J.
Chang, Lee C.
Iosifescu, Dan V.
Murrough, James
Debattista, Charles
Schatzberg, Alan F.
Trivedi, Madhukar H.
Jha, Manish K.
Sanacora, Gerard
Wilkinson, Samuel T.
Papakostas, George I.
SpringerLink (Online service)
- DOI
-
10.1038/s41380-018-0256-5
- URN
-
urn:nbn:de:101:1-2018111300230156077150
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fava, Maurizio
- Freeman, Marlene P.
- Flynn, Martina
- Judge, Heidi
- Hoeppner, Bettina B.
- Cusin, Cristina
- Ionescu, Dawn F.
- Mathew, Sanjay J.
- Chang, Lee C.
- Iosifescu, Dan V.
- Murrough, James
- Debattista, Charles
- Schatzberg, Alan F.
- Trivedi, Madhukar H.
- Jha, Manish K.
- Sanacora, Gerard
- Wilkinson, Samuel T.
- Papakostas, George I.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
A randomized controlled pilot study of daily intravenous ketamine over three days for treatment-resistant depression
Remission of severe, treatment-resistant schizophrenia following adjunctive cannabidiol
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatment-Resistant Depression
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
Personalized use of ketamine and esketamine for treatment-resistant depression
Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study
Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Ketamine and chronic treatment-resistant depression: real-world practice and after relapse
Understanding the variability in ketamine’s efficacy in managing treatment-resistant depression
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
A randomized controlled pilot study of daily intravenous ketamine over three days for treatment-resistant depression
Remission of severe, treatment-resistant schizophrenia following adjunctive cannabidiol
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatment-Resistant Depression
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
Personalized use of ketamine and esketamine for treatment-resistant depression
Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study
Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Ketamine and chronic treatment-resistant depression: real-world practice and after relapse
Understanding the variability in ketamine’s efficacy in managing treatment-resistant depression
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
A randomized controlled pilot study of daily intravenous ketamine over three days for treatment-resistant depression
Remission of severe, treatment-resistant schizophrenia following adjunctive cannabidiol
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatment-Resistant Depression
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
Personalized use of ketamine and esketamine for treatment-resistant depression
Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study
Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Ketamine and chronic treatment-resistant depression: real-world practice and after relapse